←Search results

Search “RAG”

By relevance · Total 3434 results Clear search

Wednesday

  14. The New Stack

    Nvidia adds Agent Knowledge Foundation to Agent Toolkit

    At GTC Berlin, Nvidia added Agent Knowledge Foundation to Agent Toolkit, packaging the Nemotron Retriever models, the new Auto-Ontology library, the Kumo family of models for structured data, and CUDA-X data processing libraries; data remains in place and is managed under enterprises' existing permissions. Nvidia says Nemotron Retriever improved search relevance by 65% in tests in the open-source OpenSearch environment, SAP's fine-tuned reranker runs nearly three times faster, and ServiceNow's reranking delivers better quality with latency reduced by nearly 25%. Auto-Ontology provides a REST API and an MCP server for agents to query, and Nvidia says it does not compete with data platforms such as Snowflake but rather partners with them.

    At GTC Berlin, Nvidia added Agent Knowledge Foundation to Agent Toolkit, packaging the Nemotron Retriever models, the new Auto-Ontology library, the Kumo family of models for structured data, and CUDA-X data processing libraries; data remains in place and is managed under enterprises' existing permissions. Nvidia says Nemotron Retriever improved search relevance by 65% in tests in the open-source OpenSearch environment, SAP's fine-tuned reranker runs nearly three times faster, and ServiceNow's r

    Matched fieldsBody

    #hot-signal#Product updates#Agents#RAG
  19. Analytics India Magazine

    OpenAI acquires Orchestra Bio to build AI agents for drug discovery

    OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug discovery projects; the terms of the deal were not disclosed. Orchestra Bio was founded in 2022 and had raised approximately $20 million by 2025, with investors including Andreessen Horowitz, Atria Ventures, and 8VC. Its team and technology will be integrated into OpenAI's Rosalind model and tool suite for life sciences research, and the two sides plan to develop AI agents capable of connecting scientific discovery with the research, decision-making, and workflows needed to advance drug candidates.

    OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug discovery projects; the terms of the deal were not disclosed. Orchestra Bio was founded in 2022 and had raised approximately $20 million by 2025, with investors including Andreessen Horowitz, Atria Ventures, and 8VC. Its team and technology will be integrated into OpenAI's Rosalind model and tool suite for life sciences research, and the two sides plan to develop AI agents capable of connecting s

    Matched fieldsBody

    #hot-signal#Industry news#Agents#OpenAI